Pages that link to "Q35100323"

The following pages link to Iron chelators as anti-neoplastic agents: current developments and promise of the PIH class of chelators (Q35100323):

Displaying 27 items.

• Iron: a target for the management of Kaposi's sarcoma? (Q24807119) (← links)
• Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (Q28388335) (← links)
• Protein kinase Cdelta-dependent and -independent signaling in genotoxic response to treatment of desferroxamine, a hypoxia-mimetic agent (Q28567211) (← links)
• Synthesis, Physicochemical Studies, Molecular Dynamics Simulations, and Metal-Ion-Dependent Antiproliferative and Antiangiogenic Properties of Cone ICL670-Substituted Calix[4]arenes (Q30615373) (← links)
• Ribonucleotide reductase metallocofactor: assembly, maintenance and inhibition (Q33699869) (← links)
• Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin. (Q34571662) (← links)
• Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities (Q35034547) (← links)
• The neglected significance of "antioxidative stress". (Q35977855) (← links)
• The Effect of Lycopene Preexposure on UV-B-Irradiated Human Keratinocytes (Q36333137) (← links)
• Venous thromboembolism prevention in cancer patients: the search for common antecedents (Q36916924) (← links)
• Synthetic and Natural Iron Chelators: Therapeutic Potential and Clinical Use (Q37290073) (← links)
• Reactions of N-benzyloxycarbamate derivatives with stabilized carbon nucleophiles: a new synthetic approach to polyhydroxamic acids and other hydroxamate-containing mixed ligand systems (Q37446333) (← links)
• Malaria and iron: history and review (Q37599856) (← links)
• Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments (Q37833060) (← links)
• Targeting ribonucleotide reductase for cancer therapy. (Q38148222) (← links)
• A review of metal-catalyzed molecular damage: protection by melatonin (Q38195865) (← links)
• Microbial siderophores and their potential applications: a review (Q38372890) (← links)
• Redox- and non-redox-metal-induced formation of free radicals and their role in human disease (Q38581859) (← links)
• Do iron chelators increase the antiproliferative effect of trichostatin A through a glucose-regulated protein 78 mediated mechanism? (Q39016184) (← links)
• Novel near-infrared fluorescent integrin-targeted DFO analogue (Q40044646) (← links)
• Tuning the antiproliferative activity of biologically active iron chelators: characterization of the coordination chemistry and biological efficacy of 2-acetylpyridine and 2-benzoylpyridine hydrazone ligands (Q40075530) (← links)
• Novel diaroylhydrazine ligands as iron chelators: coordination chemistry and biological activity. (Q40367516) (← links)
• Two routes of iron accumulation in astrocytes: ascorbate-dependent ferrous iron uptake via the divalent metal transporter (DMT1) plus an independent route for ferric iron. (Q42916945) (← links)
• Cytotoxic iron chelators: characterization of the structure, solution chemistry and redox activity of ligands and iron complexes of the di-2-pyridyl ketone isonicotinoyl hydrazone (HPKIH) analogues (Q44621428) (← links)
• Synthesis of Dipyridyl Ketone Isonicotinoyl Hydrazone Copper(II) Complex: Structure, Anticancer Activity and Anticancer Mechanism (Q46468084) (← links)
• 3-Chloro-'-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy (Q58758722) (← links)
• Intra-molecular 1,5-S⋯N σ-hole inter-action in (E)-N'-(pyridin-4-yl-methyl-idene)thio-phene-2-carbohydrazide (Q91842255) (← links)